NCT03705117View on ClinicalTrials.gov

Open-label V565 Target Engagement Study

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 23, 2017

Primary Completion Date

October 24, 2017

Study Completion Date

October 24, 2017

Conditions
Ulcerative Colitis
Interventions
BIOLOGICAL

V565

Capsules for oral administration

Trial Locations (1)

E1 1BB

The Royal London Hospital, London

All Listed Sponsors
lead

VHsquared Ltd.

INDUSTRY

NCT03705117 - Open-label V565 Target Engagement Study | Biotech Hunter | Biotech Hunter